Alimera Sciences: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Thursday reported a loss of $3.8 million in its fourth quarter.

On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 7 cents.

The eye drug developer posted revenue of $26.3 million in the period.

For the year, the company reported that its loss widened to $20.1 million, or 79 cents per share. Revenue was reported as $80.8 million.

Alimera Sciences expects full-year revenue of $105 million.

The company's shares closed at $3.87. A year ago, they were trading at $2.23.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM

Advertisement

Recommended Stories